- A new study tracked nearly 180 hospitalized COVID-19 patients in Florida for up to a year.
- Adults with severe COVID-19 were twice as likely as uninfected people to die within a year.
Nearly 180 people left the University of Florida health system alive after being hospitalized with severe COVID-19 during the US's first wave of
The researchers examined more than 13,000 patient records from January to June of last year, before
The study found that adults who recovered from severe COVID-19 were twice as likely as uninfected people to die within a year of contracting the disease.
"A lot of times when people have an infectious disease, they have it and then the episode ends and it's pretty much gone," Arch Mainous, the study's lead investigator, told Insider. But COVID-19 is different, he said: "Just because you get out of the hospital, it's not over."
Younger adults faced a particularly high risk of long-term health problems: COVID-19 patients under 65 who were initially discharged from the hospital were three times as likely as uninfected people to die within a year.
Adults older than 65 are more likely to succumb to COVID-19 quickly, so many won't ever reach the recovery stage, Mainous said. Younger adults, on the other hand, are more likely to survive an initial infection, then suffer from lingering symptoms for months, or perhaps years, to come.
"The internal trauma of having a severe COVID episode is manifested even more so in these young people," Mainous said.
Researchers aren't sure why COVID-19 patients are dying of long-term complications, but Mainous has a theory. COVID-19 may ignite a persistent inflammatory response, which wreaks havoc on a person's organs even after they've cleared the virus, increasing their risk of heart attack, pneumonia, kidney failure, or stroke.
"We believe that there's a huge inflammatory response which is systemic and that's why we don't see it localized only in one spot," he said.
COVID-19 wasn't listed as a cause of death for any of the deceased patients in his study, he added, which implies the disease may be even deadlier than available data suggests. A model from The Economist in May, for example, suggested that at least half the world's
Persistent inflammation could damage the heart, lungs, or kidneys
Severe COVID-19 generally results in three negative health outcomes, Mainous said: blood clots, respiratory problems, and cardiovascular issues.
A January study in The Lancet found that up to 56% of hospitalized COVID-19 patients showed signs of lung problems six months after their initial COVID-19 symptoms.
Mainous' research team found in July that people hospitalized with severe COVID-19 were more than twice as likely as patients with milder COVID-19 to be hospitalized again because of health complications from the disease. Those complications included heart attacks, stroke, pneumonia, and pulmonary embolism — a blockage in a lung artery caused by a blood clot.
Curiously, though, most hospitalized COVID-19 patients in the new study didn't die of cardiovascular, respiratory, or clotting problems. Instead, those conditions represented just 20% of deaths among hospitalized people who initially recovered from severe COVID-19.
Mainous said an aggressive inflammatory response in some patients could damage organs besides the heart and lungs, such as the brain, liver, or kidneys.
"There may be some sort of organ system dysregulation that we didn't think about and that we're not monitoring," he said.
Getting vaccinated, he added, reduces the risk of winding up in the hospital in the first place. COVID-19 vaccines remain highly effective at preventing severe disease, hospitalization, and death.